Version 5.4
Homo sapiens Protein: ABO
Summary
InnateDB Protein IDBP-807862.1
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol ABO
Protein Name ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
Synonyms A3GALNT; A3GALT1; GTB; NAGAT;
Species Homo sapiens
Ensembl Protein ENSP00000483018
InnateDB Gene IDBG-90910 (ABO)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 3 experimentally validated interaction(s) in this database.
Experimentally validated
Total 3 [view]
Protein-Protein 3 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0004380 glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity
GO:0004381 fucosylgalactoside 3-alpha-galactosyltransferase activity
GO:0016758 transferase activity, transferring hexosyl groups
Biological Process
GO:0005975 carbohydrate metabolic process
Cellular Component
GO:0016020 membrane
Protein Structure and Domains
PDB ID
InterPro IPR005076 Glycosyl transferase, family 6
IPR029044 Nucleotide-diphospho-sugar transferases
PFAM PF03414
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL Q9UP70
UniProt Splice Variant
Entrez Gene 28
UniGene
RefSeq
HUGO HGNC:79
OMIM 110300
CCDS
HPRD
IMGT
EMBL AB052642 AF062486 AF324013 JN652591
GenPept AAC99327 AAL37345 AEZ53688 BAB32655

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca